P04150 (GCR_HUMAN) Homo sapiens (Human)

Glucocorticoid receptor UniProtKBInterProSTRINGInteractive Modelling

777 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 6; Isoform 5; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12; Isoform 13; Isoform 14; Isoform 15; Isoform 16); 1 identical sequence: Homo sapiens: F1D8N4

Available Structures

58 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The glucocorticoid receptor in complex with velsecorat, a PGC1a coactivator fragment and sgk 23bp Heteromer
Q9UBK2;
415-777
ZN;EDO;82H;
Assess
The glucocorticoid receptor in complex with fluticasone furoate, a PGC1a coactivator fragment and s… Heteromer
Q9UBK2;
417-776
ZN;EDO;GW6;
Assess
Cryo-EM structure of the GR-Hsp90-FKBP51 complex Heteromer
P07900; Q13451;
519-777
ATP;MG;DEX;
Assess
Atomic cryoEM structure of Hsp90-Hsp70-Hop-GR Heteromer
P07900; P0DMV8; P31948;
519-777
ADP;MG;K;
Assess
Cryo-EM structure of the GR-Hsp90-FKBP52 complex Heteromer
P07900; Q02790;
519-777
ATP;MG;DEX;
Assess
Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bou… Heteromer
Q15596;
523-777
BOG;DEX;
Assess
The GR-Maturation Complex: Glucocorticoid Receptor in complex with Hsp90 and co-chaperone p23 Heteromer
P07900; Q15185;
523-777
ATP;MG;DEX;
Assess
Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol Heteromer
Q15788;
525-777
DAY;
Assess
Crystal Structure of mometasone furoate-bound glucocorticoid receptor ligand binding domain Heteromer
Q15596;
526-777
MOF;
Assess
Glucocorticoid Receptor LBD bound to GSK866 Heteromer
Q15596;
525-776
866;GOL;
Assess
Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain Heteromer
Q15596;
526-777
HCY;
Assess
Glucocorticoid Receptor with Bound D-prolinamide 11 Heteromer
Q15596;
525-776
JZN;
Assess
Glucocorticoid Receptor with Bound alaninamide 10 with TIF2 peptide Heteromer
Q15596;
526-776
JZS;JZR;
Assess
Ligand binding domain of the glucocorticoid receptor complexed with fluticazone furoate Heteromer
Q15596;
526-776
GW6;
Assess
Crystal structure of Glucocorticoid Receptor in complex with an inhibitor Heteromer
Q15596;
528-777
A1ACE;
Assess
CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR Heteromer
Q15596;
527-776
DEX;
Assess
GR in complex with desisobutyrylciclesonide Heteromer
Q15596;
529-777
CPS;EDO;CV7;
Assess
Crystal structure of the antagonist form of human glucocorticoid receptor Heteromer
O75376;
528-776
486;
Assess
wildtype ligand binding domain of the glucocorticoid receptor complexed with velsecorat and a PGC1a… Heteromer
Q9UBK2;
529-776
82H;
Assess
Glucocorticoid Receptor in complex with AZD5423 Heteromer
Q15596;
529-776
EDO;8W8;
Assess
Discovery of New Selective Glucocorticoid Receptor Agonist Leads Heteromer
Q15596;
529-776
CPS;EDO;E7T;
Assess
GR in complex with dexamethasone Heteromer
Q15596;
529-776
CPS;DEX;
Assess
Glucocorticoid Receptor in complex with budesonide Heteromer
Q15596;
530-776
CPS;EDO;GOL;8W5;
Assess
Glucocorticoid Receptor in complex with compound 31 Heteromer
Q15596;
530-776
EDO;B9T;
Assess
Glucocorticoid Receptor in complex with AZD9567 Heteromer
Q15596;
530-776
EDO;B9W;
Assess
Structure guided design and discovery of Indazole ethers as highly potent, non-steroidal Glucocorti… Heteromer
Q15596;
530-776
EDO;R8C;
Assess
The discovery of potent selective glucocorticoid receptor modulators, suitable for inhalation Heteromer
Q15596;
530-776
EDO;NN7;
Assess
Crystal Structure of the Glucocorticoid Receptor Bound to a Non-steroidal Antagonist Reveals Reposi… Heteromer
O75376;
530-776
29M;
Assess
Glucocorticoid Receptor in complex with compound 4 Heteromer
Q15596;
530-776
EDO;B9Q;
Assess
Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pT524 pS617 peptide Heteromer
P63104;
520-621
Assess
Binary complex of 14-3-3 zeta Glucocorticoid Receptor (GR) pT524 peptide stabilised by (R)-para chl… Heteromer
P63104;
518-530
BTB;QJK;MG;
Assess
Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pT524 peptide Heteromer
P63104;
519-530
Assess
Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pS617 peptide Heteromer
P63104;
615-620
SAL;SO4;
Assess
Structure of the dominant negative mutant Glucocorticoid Receptor alpha (L733K/N734P) complexed wit…homo-4-mer526-776
486;MPD; 18×EDO;EPE;
Assess
Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Bound to a Dibenzoxapine Sul…homo-2-mer526-777
LSJ;
Assess
Glucocorticoid Receptor in complex with Compound 11homo-2-mer530-777
HJ4;
Assess
Glucocorticoid receptor DNA binding domain - CCL2 NF-kB response element complexhomo-2-mer418-495
ZN;
Assess
AncGR2 DNA Binding Domain - (+)GRE Complexhomo-2-mer417-492
ZN;
Assess
S425G Glucocorticoid receptor DNA binding domain - (+)GRE complexhomo-2-mer417-491
ZN;
Assess
AncGR DNA Binding Domain - (+)GRE Complexhomo-2-mer417-490
ZN;
Assess
AncMR DNA Binding Domain - (+)GRE Complexhomo-2-mer418-491
ZN;
Assess
Glucocorticoid receptor DNA binding domain - RELB NF-kB response element complexhomo-2-mer417-490
ZN;
Assess
Glucocorticoid Receptor DNA binding domain in complex with unmodified precursor for a modern recogn…homo-2-mer417-490
ZN;CAC;
Assess
Glucocorticoid receptor DNA binding domain - IL8 NF-kB response element complexhomo-2-mer418-490
ZN;
Assess
GR DNA Binding Domain - TSLP nGRE Complexhomo-2-mer418-490
ZN;
Assess
Glucocorticoid Receptor DNA binding domain in complex with methylated precursor for a modern recogn…homo-2-mer419-491
ZN;
Assess
Glucocorticoid receptor DNA binding domain - PLAU NF-kB response element complexhomo-2-mer418-490
ZN;
Assess
Glucocorticoid receptor DNA binding domain - ICAM1 NF-kB response element complexhomo-2-mer418-490
ZN;
Assess
Glucocorticoid Receptor DNA Binding Domain in complex with AP-1 response element from VCAM-1 Promot…homo-2-mer419-490
ZN;
Assess
Transcription factor GRDBD and mmGRE complexhomo-2-mer419-490
ZN;
Assess
Transcription factor GRDBD and GRE complexhomo-2-mer418-489
ZN;
Assess
Transcription factor GRDBD and smGRE complexhomo-2-mer418-489
ZN;
Assess
GR DNA Binding Domain R460D/D462R - TSLP nGRE Complexhomo-2-mer419-490
ZN;
Assess
Glucocorticoid Receptor DNA Binding Domain - IL11 AP-1 recognition element Complexhomo-2-mer419-488
ZN;
Assess
Human GR (418-507) in complex with monomeric DNA binding sitehomo-2-mer421-490
ZN;
Assess
Structural Analysis of Glucocorticoid Receptor beta Ligand Binding Domain Complexed with Glucocorti…homo-2-mer524-549
486;CPS;CL;MPD;EDO;
Assess
Crystal Structure of the Antagonist Form of Glucocorticoid Receptormonomer530-776
486;HEZ;
Assess
Crystal Structure of the DNA-free Glucocorticoid Receptor DNA Binding Domainmonomer419-498
ZN;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7prw.1.Bmonomer0.77418-777
ZN;82H;98.73
Assess
7prw.1.Amonomer0.77415-777
ZN;82H;98.72
Assess
7kw7.1.Fmonomer0.72519-777
99.74
Assess
3dzy.1.Bmonomer0.58418-759
ZN;21.19
Assess

52 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27prw.1.Amonomer0.75415-733
ZN;97.41
Assess
Isoform 27prw.1.Bmonomer0.75418-733
ZN;97.41
Assess
Isoform 27kw7.1.Fmonomer0.69519-733
99.18
Assess
Isoform 23dzy.1.Bmonomer0.57418-730
ZN;22.15
Assess
Isoform 37prw.1.Bmonomer0.77418-778
ZN;82H;98.73
Assess
Isoform 37prw.1.Amonomer0.76415-778
ZN;82H;98.73
Assess
Isoform 37kw7.1.Fmonomer0.72520-778
99.74
Assess
Isoform 33dzy.1.Bmonomer0.57418-760
ZN;21.19
Assess
Isoform 57prv.1.Amonomer0.76417-488
ZN;94.55
Assess
Isoform 51m2z.1.Cmonomer0.67481-593
92.92
Assess
Isoform 67prw.1.Amonomer0.75415-734
ZN;97.41
Assess
Isoform 67prw.1.Bmonomer0.73418-734
ZN;97.41
Assess
Isoform 67kw7.1.Fmonomer0.67520-734
99.05
Assess
Isoform 63dzy.1.Bmonomer0.58418-731
ZN;22.15
Assess
Isoform 73dzy.1.Amonomer0.66418-499
ZN;30.05
Assess
Isoform 74udb.1.Amonomer0.61456-545
47.73
Assess
Isoform 87prw.1.Bmonomer0.75392-751
ZN;82H;98.73
Assess
Isoform 87prw.1.Amonomer0.75389-751
ZN;82H;98.73
Assess
Isoform 87kw7.1.Fmonomer0.72493-751
99.73
Assess
Isoform 83dzy.1.Bmonomer0.57392-733
ZN;21.19
Assess
Isoform 97prw.1.Bmonomer0.73392-707
ZN;97.41
Assess
Isoform 97prw.1.Amonomer0.72389-707
ZN;97.41
Assess
Isoform 97kw7.1.Fmonomer0.68493-707
98.87
Assess
Isoform 93dzy.1.Bmonomer0.58392-704
ZN;22.15
Assess
Isoform 107prw.1.Bmonomer0.77392-751
ZN;82H;98.73
Assess
Isoform 107prw.1.Amonomer0.77389-751
ZN;82H;98.73
Assess
Isoform 107kw7.1.Fmonomer0.72493-751
98.80
Assess
Isoform 103dzy.1.Bmonomer0.58392-733
ZN;21.19
Assess
Isoform 117prw.1.Bmonomer0.76333-692
ZN;82H;98.73
Assess
Isoform 117prw.1.Amonomer0.76330-692
ZN;82H;98.72
Assess
Isoform 117kw7.1.Fmonomer0.72434-692
99.71
Assess
Isoform 113dzy.1.Bmonomer0.57333-674
ZN;21.19
Assess
Isoform 127prw.1.Bmonomer0.76329-688
ZN;82H;98.73
Assess
Isoform 127prw.1.Amonomer0.76326-688
ZN;82H;98.72
Assess
Isoform 127kw7.1.Fmonomer0.72430-688
99.71
Assess
Isoform 123dzy.1.Bmonomer0.57329-670
ZN;21.19
Assess
Isoform 137prw.1.Bmonomer0.76321-680
ZN;82H;98.73
Assess
Isoform 137prw.1.Amonomer0.76318-680
ZN;82H;98.72
Assess
Isoform 137kw7.1.Fmonomer0.72422-680
99.71
Assess
Isoform 133dzy.1.Bmonomer0.57321-662
ZN;21.19
Assess
Isoform 147prw.1.Bmonomer0.77103-462
ZN;82H;98.73
Assess
Isoform 147prw.1.Amonomer0.77100-462
ZN;82H;98.72
Assess
Isoform 147kw7.1.Fmonomer0.73204-462
99.57
Assess
Isoform 143dzy.1.Bmonomer0.56103-444
ZN;21.19
Assess
Isoform 157prw.1.Bmonomer0.7788-447
ZN;82H;98.73
Assess
Isoform 157prw.1.Amonomer0.7785-447
ZN;82H;98.72
Assess
Isoform 157kw7.1.Fmonomer0.73189-447
99.55
Assess
Isoform 153dzy.1.Bmonomer0.5688-429
ZN;21.19
Assess
Isoform 167prw.1.Bmonomer0.7783-442
ZN;82H;98.73
Assess
Isoform 167prw.1.Amonomer0.7780-442
ZN;82H;98.73
Assess
Isoform 167kw7.1.Fmonomer0.73184-442
99.55
Assess
Isoform 163dzy.1.Bmonomer0.5683-424
ZN;21.19
Assess